These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8641041)

  • 21. Use of nimodipine is safe.
    Heininger K; Kuebler J
    Stroke; 1996 Oct; 27(10):1911-3. PubMed ID: 8841354
    [No Abstract]   [Full Text] [Related]  

  • 22. Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
    Kragten JA; Dunselman PH
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):643-53. PubMed ID: 17605643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 24. Back to basics: diuretics as first-line agents in the treatment of hypertension.
    Mandal VJ
    J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 26. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Generalized Exanthematous Pustulosis Secondary to Nifedipine.
    Shrestha A; Rizzo V
    S D Med; 2016 May; 69(5):199-201. PubMed ID: 28863416
    [No Abstract]   [Full Text] [Related]  

  • 28. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 29. [Which antihypertensive agents are best? Results of two new meta-analyses are enriching but don't stop the discussion].
    Nilsson P
    Lakartidningen; 2001 Mar; 98(10):1082-3. PubMed ID: 11301973
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers.
    Akintonwa DA; Odigwe CO
    Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should calcium antagonists be first line drugs in hypertension?
    Furberg CD; Psaty BM
    Herz; 1995 Dec; 20(6):365-9. PubMed ID: 8582696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium antagonists and their impact on coronary risk].
    Rodríguez Moreno C
    Med Clin (Barc); 1998 Feb; 110(6):237. PubMed ID: 9547737
    [No Abstract]   [Full Text] [Related]  

  • 35. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
    Christensen KL
    Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and efficacy of first-line antihypertensives.
    Strickland C
    J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619
    [No Abstract]   [Full Text] [Related]  

  • 39. The nifedipine scare in hypertension: fact or fiction.
    Gambhir DS
    Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005
    [No Abstract]   [Full Text] [Related]  

  • 40. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.